Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs
Files
(Published version)
Date
2013
Authors
Secret, E.
Smith, K.
Dubljevic, V.
Moore, E.
Macardle, P.
Delalat, B.
Rogers, M.L.
Johns, T.G.
Durand, J.O.
Cunin, F.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Advanced healthcare materials, 2013; 2(5):718-727
Statement of Responsibility
Conference Name
Abstract
We describe the preparation of biodegradable porous silicon nanoparticles (pSiNP) functionalized with cancer cell targeting antibodies and loaded with the hydrophobic anti-cancer drug camptothecin. Orientated immobilization of the antibody on the pSiNP is achieved using novel semicarbazide based bioconjugate chemistry. To demonstrate the generality of this targeting approach, the three antibodies MLR2, mAb528 and Rituximab are used, which target neuroblastoma, glioblastoma and B lymphoma cells, respectively. Successful targeting is demonstrated by means of flow cytometry and immunocytochemistry both with cell lines and primary cells. Cell viability assays after incubation with pSiNPs show selective killing of cells expressing the receptor corresponding to the antibody attached on the pSiNP.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2013 Wiley-VCH GmbH
Access Condition Notes: Preprint only available on Open Access